SE9703458D0 - Nicotine compositions and methods of formulation thereof - Google Patents

Nicotine compositions and methods of formulation thereof

Info

Publication number
SE9703458D0
SE9703458D0 SE9703458A SE9703458A SE9703458D0 SE 9703458 D0 SE9703458 D0 SE 9703458D0 SE 9703458 A SE9703458 A SE 9703458A SE 9703458 A SE9703458 A SE 9703458A SE 9703458 D0 SE9703458 D0 SE 9703458D0
Authority
SE
Sweden
Prior art keywords
offspring
precursors
liquid crystals
dispersions
nicotine
Prior art date
Application number
SE9703458A
Other languages
English (en)
Inventor
Sven Boerje Andersson
Stefan Jonn
Tomas Landh
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Priority to SE9703458A priority Critical patent/SE9703458D0/sv
Publication of SE9703458D0 publication Critical patent/SE9703458D0/sv
Priority to DK98945685T priority patent/DK1023069T3/da
Priority to CN98810645A priority patent/CN1123343C/zh
Priority to KR1020007003204A priority patent/KR20010024305A/ko
Priority to DE69819548T priority patent/DE69819548T2/de
Priority to BR9815395-1A priority patent/BR9815395A/pt
Priority to PCT/SE1998/001632 priority patent/WO1999015171A1/en
Priority to AT98945685T priority patent/ATE253362T1/de
Priority to NZ50340898A priority patent/NZ503408A/xx
Priority to EP98945685A priority patent/EP1023069B1/en
Priority to HU0004802A priority patent/HUP0004802A3/hu
Priority to AU92872/98A priority patent/AU733619B2/en
Priority to ES98945685T priority patent/ES2210817T3/es
Priority to EEP200000154A priority patent/EE200000154A/xx
Priority to JP2000512540A priority patent/JP2001517624A/ja
Priority to CA002304042A priority patent/CA2304042A1/en
Priority to MXPA00002955A priority patent/MXPA00002955A/es
Priority to RU2000110632/14A priority patent/RU2201747C2/ru
Priority to PT98945685T priority patent/PT1023069E/pt
Priority to ZA988794A priority patent/ZA988794B/xx
Priority to NO20001540A priority patent/NO20001540L/no
Priority to FI20000692A priority patent/FI20000692A/sv
Priority to US10/389,148 priority patent/US20030176467A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Dispersion Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE9703458A 1997-09-25 1997-09-25 Nicotine compositions and methods of formulation thereof SE9703458D0 (sv)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SE9703458A SE9703458D0 (sv) 1997-09-25 1997-09-25 Nicotine compositions and methods of formulation thereof
PT98945685T PT1023069E (pt) 1997-09-25 1998-09-15 Composicoes de nicotina e seus processos de formulacao
HU0004802A HUP0004802A3 (en) 1997-09-25 1998-09-15 Nicotine compositions and methods of formulation thereof
ES98945685T ES2210817T3 (es) 1997-09-25 1998-09-15 Composiciones de nicotina y metodos de formulacion de las mismas.
KR1020007003204A KR20010024305A (ko) 1997-09-25 1998-09-15 니코틴 조성물 및 이의 제형화 방법
DE69819548T DE69819548T2 (de) 1997-09-25 1998-09-15 Nicotin enthaltende zusammensetzungen und verfahren zur ihrer formulierung
BR9815395-1A BR9815395A (pt) 1997-09-25 1998-09-15 Composições à base de nicotina e método de formulção das mesmas
PCT/SE1998/001632 WO1999015171A1 (en) 1997-09-25 1998-09-15 Nicotine compositions and methods of formulation thereof
AT98945685T ATE253362T1 (de) 1997-09-25 1998-09-15 Nicotin enthaltende zusammensetzungen und verfahren zur ihrer formulierung
NZ50340898A NZ503408A (en) 1997-09-25 1998-09-15 Nicotine compositions containing a local analgesuc or polar lipids and anionic surfactants
EP98945685A EP1023069B1 (en) 1997-09-25 1998-09-15 Nicotine compositions and methods of formulation thereof
DK98945685T DK1023069T3 (da) 1997-09-25 1998-09-15 Nikotinsammensætninger og fremgangsmåder til fremstilling deraf
AU92872/98A AU733619B2 (en) 1997-09-25 1998-09-15 Nicotine compositions and methods of formulation thereof
CN98810645A CN1123343C (zh) 1997-09-25 1998-09-15 烟碱组合物及其制备方法
EEP200000154A EE200000154A (et) 1997-09-25 1998-09-15 Nikotiini sisaldav kompositsioon ja selle valmistamismeetod
JP2000512540A JP2001517624A (ja) 1997-09-25 1998-09-15 ニコチン組成物およびその製剤方法
CA002304042A CA2304042A1 (en) 1997-09-25 1998-09-15 Nicotine compositions and methods of formulation thereof
MXPA00002955A MXPA00002955A (es) 1997-09-25 1998-09-15 Composiciones de nicotina y metodos de formulacion de las mismas.
RU2000110632/14A RU2201747C2 (ru) 1997-09-25 1998-09-15 Композиция, заменяющая табак (варианты), способ ее получения, способ лечения табакокурения, способ лечения болезни альцгеймера, болезни паркинсона или неспецифического язвенного колита
ZA988794A ZA988794B (en) 1997-09-25 1998-09-25 Nicotine compositions and methods of formulation thereof
NO20001540A NO20001540L (no) 1997-09-25 2000-03-24 Nikotinblandinger, samt fremgangsmÕter ved fremstilling derav
FI20000692A FI20000692A (sv) 1997-09-25 2000-03-24 Nikotinkompositioner och förfarande för deras sammansättning
US10/389,148 US20030176467A1 (en) 1997-09-25 2003-03-14 Nicotine compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703458A SE9703458D0 (sv) 1997-09-25 1997-09-25 Nicotine compositions and methods of formulation thereof

Publications (1)

Publication Number Publication Date
SE9703458D0 true SE9703458D0 (sv) 1997-09-25

Family

ID=20408364

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9703458A SE9703458D0 (sv) 1997-09-25 1997-09-25 Nicotine compositions and methods of formulation thereof

Country Status (22)

Country Link
EP (1) EP1023069B1 (sv)
JP (1) JP2001517624A (sv)
KR (1) KR20010024305A (sv)
CN (1) CN1123343C (sv)
AT (1) ATE253362T1 (sv)
AU (1) AU733619B2 (sv)
BR (1) BR9815395A (sv)
CA (1) CA2304042A1 (sv)
DE (1) DE69819548T2 (sv)
DK (1) DK1023069T3 (sv)
EE (1) EE200000154A (sv)
ES (1) ES2210817T3 (sv)
FI (1) FI20000692A (sv)
HU (1) HUP0004802A3 (sv)
MX (1) MXPA00002955A (sv)
NO (1) NO20001540L (sv)
NZ (1) NZ503408A (sv)
PT (1) PT1023069E (sv)
RU (1) RU2201747C2 (sv)
SE (1) SE9703458D0 (sv)
WO (1) WO1999015171A1 (sv)
ZA (1) ZA988794B (sv)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
US8256433B2 (en) 1999-07-16 2012-09-04 Aradigm Corporation Systems and methods for effecting cessation of tobacco use
US6799576B2 (en) 1999-07-16 2004-10-05 Aradigm Corporation System for effecting smoking cessation
AT409219B (de) * 1999-08-13 2002-06-25 Red Bull Gmbh Verwendung von nikotin zum herstellen von arzneimitteln
KR100381622B1 (ko) * 2000-08-30 2003-04-26 디디에스텍주식회사 자극성을 줄인 염기성 약물의 구강 투여 조성물
DE10057769A1 (de) * 2000-11-22 2002-05-23 Beiersdorf Ag Haarpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
WO2003082240A1 (de) * 2002-03-30 2003-10-09 Beisel Guenther Zubereitung enthaltend fettsäure zur appetitminderung, sättigung und/oder gewichtsreduktion
US20040002520A1 (en) * 2002-07-01 2004-01-01 Soderlund Patrick L. Composition and method for cessation of Nicotine cravings
KR100443722B1 (ko) * 2002-09-26 2004-08-09 이용원 니코틴을 함유한 하드츄잉캔디 및 그의 제조방법
KR20050096922A (ko) 2002-12-20 2005-10-06 니코노범 에이비 물리적 및 화학적으로 안정된 니코틴 함유 입자물질
FR2851470B1 (fr) * 2003-02-20 2007-11-16 Besins Int Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse
US9254294B2 (en) 2003-02-24 2016-02-09 Pharmaceutical Productions Inc. Transmucosal hormone delivery system
US10172810B2 (en) 2003-02-24 2019-01-08 Pharmaceutical Productions, Inc. Transmucosal ketamine delivery composition
US9498454B2 (en) * 2003-02-24 2016-11-22 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US9358296B2 (en) 2003-02-24 2016-06-07 Pharmaceutical Productions Inc. Transmucosal drug delivery system
EP1599186B1 (en) * 2003-02-24 2013-04-10 Pharmaceutical Productions Inc. Transmucosal drug delivery system
GB0322033D0 (en) * 2003-09-19 2003-10-22 Camurus Ab Composition
EP1691631A4 (en) 2003-11-07 2012-09-05 Us Smokeless Tobacco Co TOBACCO COMPOSITIONS
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US7125954B2 (en) 2005-01-27 2006-10-24 General Electric Company Method for producing polyether polymers
US20080219935A1 (en) * 2005-07-08 2008-09-11 Sang-Hoon Kwak Phase Transitive Breath Care Products
AU2007224584A1 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
CA2649149A1 (en) * 2006-04-11 2007-10-25 Koko Kosmetikvertrieb Gmbh & Co. Kg Nanoparticle containing nicotine and/or cotinine, dispersions, and use thereof
US20080287507A1 (en) * 2007-05-16 2008-11-20 John Hedenstrom Nicotine containing toiletry waters
GB2469792A (en) * 2009-04-23 2010-11-03 Calvin John Ross Oil-based pharmaceutical formulation for sublingual delivery
GB2476471A (en) * 2009-12-22 2011-06-29 Norwich Pharma Technologies Ltd Cotinine formulation for the treatment of obesity
US8846725B2 (en) * 2011-01-24 2014-09-30 Quadex Pharmaceuticals, Llc Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
CN102552405B (zh) * 2012-03-21 2013-10-16 张伟 一种肛周术后麻醉镇痛的药物组合物的制备方法
CN103040741B (zh) * 2012-12-11 2014-11-05 中山大学 溶致液晶的前体混悬液及其制备方法
US20160015703A1 (en) * 2013-03-07 2016-01-21 Danmarks Tekniske Universitet Nano- microdelivery systems for oromucosal delivery of an active ingredient
IL297399B2 (en) * 2013-05-06 2024-02-01 Juul Labs Inc Nicotine salt formulations for aerosol devices and methods thereof
WO2015090337A1 (en) * 2013-12-20 2015-06-25 Fertin Pharma A/S Nicotine powder composition
KR20170003926A (ko) * 2014-04-08 2017-01-10 산사 코포레이션 (바베이도스) 인코포레이티드 니코틴 제형 및 이의 제조방법
GB201414919D0 (en) * 2014-08-21 2014-10-08 Corbitt Terence Simon Formulations for transmucosal delivery
CN108323791B (zh) * 2018-01-03 2021-02-12 云南中烟工业有限责任公司 一种尼古丁-氧化锌复合物、其制备方法及包含其的烟草制品
JP2021530431A (ja) * 2018-04-16 2021-11-11 ポビバ コーポレーションPoviva Corp. ニコチン化合物を含ませた組成物及び其れ等の使用の方法
CN109125251B (zh) * 2018-09-10 2021-08-13 武汉百纳礼康生物制药有限公司 一种包载蛋白类药物的温敏性液晶凝胶制剂及其制备方法
KR102186704B1 (ko) 2019-02-18 2020-12-04 (주)아이엠디팜 서방성 지질 전구 제제 및 이를 포함하는 지질 용액 형태의 서방성 주사용 약학 조성물
LU101511B1 (en) * 2019-12-02 2021-06-04 Herrera Arturo Solis (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a parenteral administration and a process for the preparation of an injectable substance
LU101520B1 (en) * 2019-12-02 2021-06-07 Herrera Arturo Solis (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a homogeneous, viscous, semi-solid topical medication and topical medication
NL2031332B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of psychoactive compounds
NL2031331B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of a short-acting psychedelic compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5371109A (en) * 1986-07-01 1994-12-06 Drilletten Ab Controlled release composition for a biologically active material dissolved or dispersed in an L2-phase
IL86170A (en) * 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
US4908213A (en) * 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine
GB2230439A (en) * 1989-04-20 1990-10-24 Alec Stanley Walter Shaw Nicotine lozenges
EP0643620B1 (en) * 1991-10-04 1999-07-21 Gs Development Ab Particles, method of preparing said particles and uses thereof
CA2231273A1 (en) * 1995-10-12 1997-04-17 Lise Sylvest Nielsen A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface

Also Published As

Publication number Publication date
WO1999015171A1 (en) 1999-04-01
ES2210817T3 (es) 2004-07-01
NO20001540D0 (no) 2000-03-24
AU9287298A (en) 1999-04-12
DE69819548D1 (de) 2003-12-11
EP1023069B1 (en) 2003-11-05
BR9815395A (pt) 2000-11-14
EE200000154A (et) 2001-02-15
ATE253362T1 (de) 2003-11-15
CA2304042A1 (en) 1999-04-01
NZ503408A (en) 2004-12-24
CN1278174A (zh) 2000-12-27
NO20001540L (no) 2000-05-25
PT1023069E (pt) 2004-02-27
ZA988794B (en) 1999-04-01
MXPA00002955A (es) 2002-04-24
KR20010024305A (ko) 2001-03-26
HUP0004802A3 (en) 2001-12-28
CN1123343C (zh) 2003-10-08
DK1023069T3 (da) 2004-03-08
EP1023069A1 (en) 2000-08-02
AU733619B2 (en) 2001-05-17
RU2201747C2 (ru) 2003-04-10
DE69819548T2 (de) 2004-08-12
JP2001517624A (ja) 2001-10-09
FI20000692A (sv) 2000-03-24
HUP0004802A2 (hu) 2001-05-28

Similar Documents

Publication Publication Date Title
SE9703458D0 (sv) Nicotine compositions and methods of formulation thereof
BR9915095A (pt) Composição farmacêutica ministrável em aerosol
ATE497745T1 (de) Zusammensetzungen mit verzögerter freisetzung mit progesteron-rezeptormodulatoren
RS20070076A (en) Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
BR0110767A (pt) Derivados de piperidina farmaceuticamente ativos, em particular como moduladores da atividade de receptor de quimiocina
HRP20050781B1 (hr) Metode i farmaceutske mješavine za pouzdano postizanje prihvatljivih razina testosterona u serumu
NZ501112A (en) Substituted pyrazoles as p38 kinase inhibitors
DK0644746T3 (da) Anvendelse af glycerin til moderering af transdermal lægemiddelafgivelse
ID30353A (id) Obat semprot topikal
BR0214806A (pt) Composições farmacêuticos de 5,7,14-triazatetraciclo-{10.3.1.02,11.0,4,9]-hexadeca-2(1 1),3,5,7,9-penteno
DE60202477D1 (de) Vorrichtung zur verabreichung einer substanz
RS20070077A (en) Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflamatory diseases
WO2000037422A3 (en) Ion channel modulating agents
ITRM920900A1 (it) Formulazione proteica coadiuvante nella prevenzione e cura delle parodontiti e di altre patologie batteriche del cavo orale.
EP1344526A4 (en) PREVENTIVE / REMEDY AGENTS FOR INFLAMMATORY DISEASES OF THE AIRWAY
WO2004024187A3 (en) Compositions to reduce congestion and methods for application thereof to the nasal membrane
ES2184880T3 (es) Asociacion hormonal estrogeno-progestageno, su procedimiento de preparacion y su utilizacion en medicamentos.
ATE276232T1 (de) Ionenkanal modulatoren
DE59914183D1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
BR0210327A (pt) Microcápsulas para proteção do hálito
DE60020556D1 (de) Ionenkanal modulierende mittel
PT1198224E (pt) Formulacoes de solucoes de esteroides para administracao por inalacao
DK0742716T3 (da) Farmaceutisk sammensætning til systemisk transdermal indgivelse med det aktive middel morphin-6-glucuronid
DE69815277T2 (de) Nimelulide enthaltendes pharmazeutisches präparat zur oralen verabreichung
Hassett Summary of the scientific literature for pain and anxiety control in dentistry.